QIAGEN N.V. (QGEN) Stock Price

QGENStock
$43.6516.00%52W
Market Cap$9.01B
P/E20.96x
PEG Ratio1.11
Div yield0.62%
Beta0.62

QGEN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-26.03%
Price vs S&P 500 (4W)-4.23%
PEG Ratio1.11
VGM Score51.67
P/E Ratio (Annual)20.96x
Indicated Dividend Yield (Annual)0.62%

QGEN Earnings Surprise History

Q2 250.63est. 0.63
Q3 250.64est. 0.62
Q4 250.62est. 0.62
Q1 260.54est. 0.54
Q2 260.62est. 0.60

QGEN Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
3.67
3.65
3.73
3.77

Industry Peers — Biological Products(183)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
QGENQIAGEN N.V.
CCC$43.65
AMGNAmgen IncCCB$442.24
GILDGilead Sciences IncCBB$148.77
MRNAModerna, Inc. Common StockDCA$158.83
ARGXargenx SE American Depositary SharesDAB$1019.49
RVMDRevolution Medicines, Inc. Common StockFA$211.38
BIIBBiogen Inc. Common StockCDB$220.77
BNTXBioNTech SE American Depositary ShareCCB$114.05
NBIXNeurocrine Biosciences IncCBC$153.37
EXELExelixis IncCBB$56.72
HALOHalozyme Therapeutics, Inc.CBA$109.32

About QIAGEN N.V.

Qiagen develops proprietary sample preparation and diagnostic solutions serving life sciences research and molecular diagnostics equally. The business model generates roughly 90% of revenue from consumables, with the remainder from instruments and services. North America represents the largest market (52% of 2024 sales), followed by EMEA (33%) and Asia-Pacific (15%).